Romero Rey Jesús, Colorado-Subizar Raquel
Department of Bariatric and Metabolic Surgery, Bariatric and Metabolic Surgical Center Obesity Health, Marigalante 60 D02 Fracc. Las Américas, Boca del Río, Veracruz, ZC, 94299, México.
Department of Bariatric and Metabolic Surgery, Bariatric and Metabolic Surgical Center Obesity Health, Marigalante 60 D02 Fracc. Las Américas, Boca del Río, Veracruz, ZC, 94299, México.
Int J Surg Case Rep. 2020;68:22-26. doi: 10.1016/j.ijscr.2020.01.051. Epub 2020 Feb 6.
Several metabolic operations have been created in an attempt to enhance the equilibrium between safety, efficacy and costs of accessible metabolic surgery in diabetic patients with low body mass index (BMI). The purpose of this study is to present the preliminary outcomes of a novel procedure.
A Gastro-Ileal Anastomosis Bypass (GIA-B) was performed in 4 diabetic patients at Boca del Rio Hospital, Veracruz, México. The study was performed between March 2018 and October 2019. GIA-B was created at point to 300 cm from ileocecal valve that was held together with gastric antrum. Outcomes are presented and discussed. At average 14.7 months follow-up all the patients improved glycated hemoglobin(A1C), decrease antidiabetic medications and lost mild weight. Two patients had complete remission of type-2 diabetes mellitus. There were no postoperative complications.
GIA-B, have a considerable metabolic effect reaching improvement of the homeostatic parameters, specially A1C, in all the cases evaluated. GIA-B appears to be technically simple and the cost is considerably lower than other metabolic procedures, especially for the saving cartridges.
GIA-B could be an alternative metabolic surgery for low-BMI diabetic patients, further studies are needed to explore this procedure.
为了改善低体重指数(BMI)糖尿病患者可及的代谢手术在安全性、疗效和成本之间的平衡,人们开展了多种代谢手术操作。本研究的目的是展示一种新手术的初步结果。
在墨西哥韦拉克鲁斯州博卡德尔里奥医院对4例糖尿病患者实施了胃-回肠吻合旁路术(GIA-B)。该研究于2018年3月至2019年10月进行。GIA-B在距回盲瓣300厘米处创建,并与胃窦相连。展示并讨论了结果。在平均14.7个月的随访中,所有患者糖化血红蛋白(A1C)均得到改善,降糖药物减少,体重略有下降。2例2型糖尿病患者完全缓解。无术后并发症。
在所有评估病例中,GIA-B具有显著的代谢效应,可改善稳态参数,尤其是A1C。GIA-B在技术上似乎很简单,成本比其他代谢手术低得多,尤其是节省了耗材。
GIA-B可能是低BMI糖尿病患者的一种替代性代谢手术,需要进一步研究来探索该手术。